Skip to main content
Erschienen in: Endocrine 1/2019

28.03.2019 | Original Article

Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China

verfasst von: Xin Huang, Qiuyi Wang, Tingting Liu, Tianjiao Pei, Dong Liu, Huili Zhu, Wei Huang

Erschienen in: Endocrine | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Insulin resistance (IR) is a common feature of polycystic ovary syndrome (PCOS). Body fat indices can be predictive markers of IR. This study is aimed to predict IR in Chinese women with PCOS of different body types based on body fat indices.

Methods

A total of 723 women diagnosed with PCOS according to Rotterdam criteria were recruited in this study and were further divided into two groups based on their BMI. All participants underwent physical examinations and ultrasound; and blood was collected from them on the days 3–5 of the menstrual cycle. Their BMI, waist-to-hip ratio (WHR), waist-to-height ratio (WHtR), lipid accumulation product (LAP) index, visceral adiposity index (VAI), and the homeostasis model assessment index of insulin resistance (HOMA-IR) were calculated. The correlations between body fat indices and HOMA-IR and receiver operating characteristic (ROC) curves were evaluated.

Results

In normal weight group (BMI < 24, n = 333), VAI (best cut-off value: 1.681, area under curve (AUC) = 0.754, P < 0.01) and LAP index (best cut-off value: 18.53, AUC = 0.734, P < 0.001) were the reliable indicators of IR based on HOMA-IR ≥ 2.77, while in overweight/obese group (BMI ≥ 24, n = 390), the BMI, WC, WHtR and LAP index had a significant correlation with HOMA-IR. The representative markers to assess IR were BMI (best cut-off value: 26.43, AUC = 0.644, P = 0.001) and WHtR (best cut-off value: 0.544, AUC = 0.604, P = 0.021).

Conclusions

Body fat indices are predictive markers of IR in Chinese PCOS women, especially in those with normal weight.
Literatur
2.
Zurück zum Zitat A. Deeks, H. Teede, L. Moran, Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC. Med. 8(1), 41 (2010)CrossRef A. Deeks, H. Teede, L. Moran, Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC. Med. 8(1), 41 (2010)CrossRef
3.
Zurück zum Zitat E. Diamantikandarakis, A. Dunaif, Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 33(6), 981–1030 (2012)CrossRef E. Diamantikandarakis, A. Dunaif, Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 33(6), 981–1030 (2012)CrossRef
4.
Zurück zum Zitat D. Wiltgen, I.G. Benedetto, L.S. Mastella, P.M. Spritzer, Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum. Reprod. 24(7), 1726–1731 (2009)CrossRef D. Wiltgen, I.G. Benedetto, L.S. Mastella, P.M. Spritzer, Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum. Reprod. 24(7), 1726–1731 (2009)CrossRef
5.
Zurück zum Zitat L.N. Matos, G.V. Giorelli, C.B. Dias, Correlation of anthropometric indicators for identifying insulin sensitivity and resistance. Sao Paulo Med. J. 129(1), 30–35 (2011)CrossRef L.N. Matos, G.V. Giorelli, C.B. Dias, Correlation of anthropometric indicators for identifying insulin sensitivity and resistance. Sao Paulo Med. J. 129(1), 30–35 (2011)CrossRef
6.
Zurück zum Zitat J.Y. Oh, Y.A. Sung, H.J. Lee et al. Optimal waist circumference for prediction of metabolic syndrome in young korean women with polycystic ovary syndrome. Obesity 18(3), 593–597 (2010)CrossRef J.Y. Oh, Y.A. Sung, H.J. Lee et al. Optimal waist circumference for prediction of metabolic syndrome in young korean women with polycystic ovary syndrome. Obesity 18(3), 593–597 (2010)CrossRef
7.
Zurück zum Zitat F. Ramezani Tehrani, S. Minooee, F. Azizi, Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study. Eur. J. Endocrinol. 171(2), 199–207 (2014)CrossRef F. Ramezani Tehrani, S. Minooee, F. Azizi, Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study. Eur. J. Endocrinol. 171(2), 199–207 (2014)CrossRef
8.
Zurück zum Zitat A.K.C. Roriz, L.C.S. Passos, C.C. de Oliveira et al. Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly. PLoS ONE 9(7), E103499 (2014)CrossRef A.K.C. Roriz, L.C.S. Passos, C.C. de Oliveira et al. Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly. PLoS ONE 9(7), E103499 (2014)CrossRef
9.
Zurück zum Zitat M.C. Amato, A. Magistro, G. Gambino, R. Vesco, C. Giordano, Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome. Eur. J. Endocrinol. 172(1), 79–88 (2015)CrossRef M.C. Amato, A. Magistro, G. Gambino, R. Vesco, C. Giordano, Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome. Eur. J. Endocrinol. 172(1), 79–88 (2015)CrossRef
10.
Zurück zum Zitat J.X. Prado Teixeira Nascimento, M.B. da Costa Chein, Lopes, R.M. de Sousa, Ad.S. Ferreira, P.A. Navarro, L.M. Oliveira Brito, Importance of lipid accumulation product index as a marker of CVD risk in PCOS women. Lipids Health Dis. 14, 62 (2015)CrossRef J.X. Prado Teixeira Nascimento, M.B. da Costa Chein, Lopes, R.M. de Sousa, Ad.S. Ferreira, P.A. Navarro, L.M. Oliveira Brito, Importance of lipid accumulation product index as a marker of CVD risk in PCOS women. Lipids Health Dis. 14, 62 (2015)CrossRef
11.
Zurück zum Zitat G.A. Abruzzese, G.E. Cerrrone, J.M. Gamez et al. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as markers of insulin resistance and metabolic associated disturbances in young argentine women with polycystic ovary syndrome. Horm. Metab. Res. 49(1), 23–29 (2017)PubMed G.A. Abruzzese, G.E. Cerrrone, J.M. Gamez et al. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as markers of insulin resistance and metabolic associated disturbances in young argentine women with polycystic ovary syndrome. Horm. Metab. Res. 49(1), 23–29 (2017)PubMed
12.
Zurück zum Zitat J.L. Chan, S. Kar, E. Vanky et al. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study. Am. J. Obstet. Gynecol. 2, 189.e1–189.e8 (2017)CrossRef J.L. Chan, S. Kar, E. Vanky et al. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study. Am. J. Obstet. Gynecol. 2, 189.e1–189.e8 (2017)CrossRef
13.
Zurück zum Zitat B. Fauser, J. Chang, R. Azziz et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19(1), 41–47 (2004)CrossRef B. Fauser, J. Chang, R. Azziz et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19(1), 41–47 (2004)CrossRef
14.
Zurück zum Zitat B. Zhou, Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin. J. Epidemiol. 23(1), 5–10 (2002) B. Zhou, Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin. J. Epidemiol. 23(1), 5–10 (2002)
15.
Zurück zum Zitat S.S.C. Yen, B.B. Jaffe, R.L. Barbieri. Reproductive Endocrinology. 4th edn. (Science, Harcourt Asia, W. B. Saunders, Print, Beijing, 2001) S.S.C. Yen, B.B. Jaffe, R.L. Barbieri. Reproductive Endocrinology. 4th edn. (Science, Harcourt Asia, W. B. Saunders, Print, Beijing, 2001)
16.
Zurück zum Zitat H.S. Kahn, The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc. Disord. 5, 26 (2005)CrossRef H.S. Kahn, The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc. Disord. 5, 26 (2005)CrossRef
17.
Zurück zum Zitat M.C. Amato, C. Giordano, M. Galia et al. Visceral Adiposity Index A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33(4), 920–922 (2010)CrossRef M.C. Amato, C. Giordano, M. Galia et al. Visceral Adiposity Index A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33(4), 920–922 (2010)CrossRef
18.
Zurück zum Zitat M. Li, R.A. McDermott, Using anthropometric indices to predict cardio-metabolic risk factors in Australian indigenous populations. Diabetes Res. Clin. Pract. 87(3), 401–406 (2010)CrossRef M. Li, R.A. McDermott, Using anthropometric indices to predict cardio-metabolic risk factors in Australian indigenous populations. Diabetes Res. Clin. Pract. 87(3), 401–406 (2010)CrossRef
19.
Zurück zum Zitat X. Guan, G. Sun, L. Zheng, W. Hu, W. Li, Y. Sun, Associations between metabolic risk factors and body mass index, waist circumference, waist-to-height ratio and waist-to-hip ratio in a Chinese rural population. J. Diabetes Invest. 7(4), 601–606 (2016)CrossRef X. Guan, G. Sun, L. Zheng, W. Hu, W. Li, Y. Sun, Associations between metabolic risk factors and body mass index, waist circumference, waist-to-height ratio and waist-to-hip ratio in a Chinese rural population. J. Diabetes Invest. 7(4), 601–606 (2016)CrossRef
20.
Zurück zum Zitat P. Dou, H. Ju, J. Shang et al. Application of receiver operating characteristic curve in the assessment of the value of body mass index, waist circumference and percentage of body fat in the Diagnosis of Polycystic Ovary Syndrome in childbearing women. J. Ovarian Res. 9(1), 51 (2016)CrossRef P. Dou, H. Ju, J. Shang et al. Application of receiver operating characteristic curve in the assessment of the value of body mass index, waist circumference and percentage of body fat in the Diagnosis of Polycystic Ovary Syndrome in childbearing women. J. Ovarian Res. 9(1), 51 (2016)CrossRef
21.
Zurück zum Zitat I.I. Androulakis, E. Kandaraki, C. Christakou et al. Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome. Clin. Endocrinol. 81(3), 426–431 (2014)CrossRef I.I. Androulakis, E. Kandaraki, C. Christakou et al. Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome. Clin. Endocrinol. 81(3), 426–431 (2014)CrossRef
22.
Zurück zum Zitat X. Chen, R. Ni, Y. Mo, L. Li, D.Z. Yang, Appropriate BMI levels for PCOS patients in Southern China. Hum. Reprod. 25(5), 1295–1302 (2010)CrossRef X. Chen, R. Ni, Y. Mo, L. Li, D.Z. Yang, Appropriate BMI levels for PCOS patients in Southern China. Hum. Reprod. 25(5), 1295–1302 (2010)CrossRef
23.
Zurück zum Zitat J.A. Nazare, J.D. Smith, A.L. Borel et al. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship with Cardiometabolic Risk/Intra-Abdominal Adiposity. Am. J. Clin. Nutr. 96(4), 714–726 (2012)CrossRef J.A. Nazare, J.D. Smith, A.L. Borel et al. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship with Cardiometabolic Risk/Intra-Abdominal Adiposity. Am. J. Clin. Nutr. 96(4), 714–726 (2012)CrossRef
24.
Zurück zum Zitat T. Du, X. Yu, J. Zhang, X. Sun, Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype. Acta Diabetol. 52(5), 855–863 (2015)CrossRef T. Du, X. Yu, J. Zhang, X. Sun, Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype. Acta Diabetol. 52(5), 855–863 (2015)CrossRef
25.
Zurück zum Zitat Z. Huang, E.L. Yong, Ethnic differences: is there an Asian phenotype for polycystic ovarian syndrome? Best Pract. Res. Clin. Obstet. Gynaecol. 37, 46–55 (2016)CrossRef Z. Huang, E.L. Yong, Ethnic differences: is there an Asian phenotype for polycystic ovarian syndrome? Best Pract. Res. Clin. Obstet. Gynaecol. 37, 46–55 (2016)CrossRef
Metadaten
Titel
Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China
verfasst von
Xin Huang
Qiuyi Wang
Tingting Liu
Tianjiao Pei
Dong Liu
Huili Zhu
Wei Huang
Publikationsdatum
28.03.2019
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2019
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-01912-1

Weitere Artikel der Ausgabe 1/2019

Endocrine 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

RAS-Blocker bei Hyperkaliämie möglichst nicht sofort absetzen

14.05.2024 Hyperkaliämie Nachrichten

Bei ausgeprägter Nierenfunktionsstörung steigen unter der Einnahme von Renin-Angiotensin-System(RAS)-Hemmstoffen nicht selten die Serumkaliumspiegel. Was in diesem Fall zu tun ist, erklärte Prof. Jürgen Floege beim diesjährigen Allgemeinmedizin-Update-Seminar.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.